Belite Bio Inc. - ADRBLTE
13F holders, Q1 2025 (March 31)18holders −4
7new positions
11sold out
1famous investor
$66.22avg. 13F price*
At the end of Q1 2025, 18 institutions reported holding Belite Bio Inc. - ADR (BLTE) in their 13F filings, down 4 from Q4 2024. 7 opened new positions and 11 sold out. The largest holders were Alyeska Investment Group, L.P. ($5.5M), State Street Corp. ($1.3M) and Geode Capital Management, LLC ($845K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Belite Bio Inc. - ADR
- CUSIP
- 07782B104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $6.2M |
| Exits | 11 | $12.1M |
All 13F filers, Q4 2024 → Q1 2025: 100,731 shares bought and 233,485 shares sold, net −132,754 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Alyeska Investment Group, L.P. | 0.02% | New | 83,623 | $5.5M |
| State Street Corp. | 0.00% | Add +0.4% | 20,098 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +90.3% | 12,753 | $845K |
| JPMorgan Chase & Co. | 0.00% | Reduce -44.2% | 8,162 | $540K |
| Citadel Advisors | 0.00% | Add +9.2% | 5,689 | $377K |
| Bank of America Corp. | 0.00% | Reduce -71.5% | 5,224 | $346K |
| HRT Financial LP | 0.00% | New | 4,117 | $272K |
| Ameriprise Financial Inc. | 0.00% | New | 3,075 | $204K |
| Virtus Investment Advisers, LLC | 0.05% | New | 2,589 | $171K |
| GAMMA Investing LLC | 0.01% | Add +43.3% | 1,849 | $122K |
| Rhumbline Advisers | 0.00% | No change | 1,435 | $95K |
| UBS Group AG | 0.00% | Reduce -95.5% | 551 | $36K |
| Morgan Stanley | 0.00% | Reduce -97.0% | 316 | $21K |
| SBI Securities Co., Ltd. | 0.00% | Add +642.9% | 104 | $7K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 49 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 14 | $927 |
| Osaic Holdings, Inc. | 0.00% | Reduce -14.3% | 6 | $397 |
| Citigroup Inc. | 0.00% | New | 3 | $199 |
"% of holder's portfolio" is BLTE's weight in each manager's 13F, not the share of Belite Bio Inc. - ADR the manager owns.